vs

Side-by-side financial comparison of Roblox Corp (RBLX) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× Roblox Corp). ResMed runs the higher net margin — 27.6% vs -22.3%, a 49.9% gap on every dollar of revenue. On growth, Roblox Corp posted the faster year-over-year revenue change (43.2% vs 11.0%). Over the past eight quarters, Roblox Corp's revenue compounded faster (32.9% CAGR vs 7.8%).

Roblox Corporation is an American video game developer based in San Mateo, California. Founded in 2004 by David Baszucki and Erik Cassel, the company is the developer of Roblox, a game platform, which was released in 2006. As of December 31, 2024, the company employs over 2,400 people.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

RBLX vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.0× larger
RMD
$1.4B
$1.4B
RBLX
Growing faster (revenue YoY)
RBLX
RBLX
+32.2% gap
RBLX
43.2%
11.0%
RMD
Higher net margin
RMD
RMD
49.9% more per $
RMD
27.6%
-22.3%
RBLX
Faster 2-yr revenue CAGR
RBLX
RBLX
Annualised
RBLX
32.9%
7.8%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
RBLX
RBLX
RMD
RMD
Revenue
$1.4B
$1.4B
Net Profit
$-316.0M
$392.6M
Gross Margin
77.7%
61.8%
Operating Margin
-25.3%
34.6%
Net Margin
-22.3%
27.6%
Revenue YoY
43.2%
11.0%
Net Profit YoY
-43.9%
13.9%
EPS (diluted)
$-0.44
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RBLX
RBLX
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.4B
$1.4B
Q3 25
$1.4B
$1.3B
Q2 25
$1.1B
$1.3B
Q1 25
$1.0B
$1.3B
Q4 24
$988.2M
$1.3B
Q3 24
$919.0M
$1.2B
Net Profit
RBLX
RBLX
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$-316.0M
$392.6M
Q3 25
$-255.6M
$348.5M
Q2 25
$-278.4M
$379.7M
Q1 25
$-215.1M
$365.0M
Q4 24
$-219.6M
$344.6M
Q3 24
$-239.3M
$311.4M
Gross Margin
RBLX
RBLX
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
77.7%
61.8%
Q3 25
78.2%
61.5%
Q2 25
78.2%
60.8%
Q1 25
78.3%
59.3%
Q4 24
77.9%
58.6%
Q3 24
77.7%
58.6%
Operating Margin
RBLX
RBLX
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
-25.3%
34.6%
Q3 25
-21.8%
33.4%
Q2 25
-29.8%
33.7%
Q1 25
-24.6%
33.0%
Q4 24
-24.7%
32.5%
Q3 24
-30.4%
31.6%
Net Margin
RBLX
RBLX
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
-22.3%
27.6%
Q3 25
-18.8%
26.1%
Q2 25
-25.8%
28.2%
Q1 25
-20.8%
28.3%
Q4 24
-22.2%
26.9%
Q3 24
-26.0%
25.4%
EPS (diluted)
RBLX
RBLX
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$-0.44
$2.68
Q3 25
$-0.37
$2.37
Q2 25
$-0.41
$2.58
Q1 25
$-0.32
$2.48
Q4 24
$-0.32
$2.34
Q3 24
$-0.37
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RBLX
RBLX
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$3.1B
$1.4B
Total DebtLower is stronger
$1.2B
$663.8M
Stockholders' EquityBook value
$394.5M
$6.3B
Total Assets
$9.6B
$8.5B
Debt / EquityLower = less leverage
2.98×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RBLX
RBLX
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$3.1B
$1.4B
Q3 25
$2.9B
$1.4B
Q2 25
$2.6B
$1.2B
Q1 25
$2.7B
$932.7M
Q4 24
$2.4B
$521.9M
Q3 24
$2.3B
$426.4M
Total Debt
RBLX
RBLX
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$1.2B
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$1.2B
$662.9M
Q3 24
$667.6M
Stockholders' Equity
RBLX
RBLX
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$394.5M
$6.3B
Q3 25
$407.6M
$6.1B
Q2 25
$353.2M
$6.0B
Q1 25
$310.7M
$5.5B
Q4 24
$221.4M
$5.3B
Q3 24
$189.9M
$5.2B
Total Assets
RBLX
RBLX
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$9.6B
$8.5B
Q3 25
$8.6B
$8.3B
Q2 25
$7.8B
$8.2B
Q1 25
$7.5B
$7.6B
Q4 24
$7.2B
$7.1B
Q3 24
$6.7B
$7.2B
Debt / Equity
RBLX
RBLX
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
2.98×
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
5.48×
0.13×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RBLX
RBLX
RMD
RMD
Operating Cash FlowLast quarter
$607.0M
Free Cash FlowOCF − Capex
$308.6M
FCF MarginFCF / Revenue
21.8%
Capex IntensityCapex / Revenue
21.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RBLX
RBLX
RMD
RMD
Q2 26
Q1 26
Q4 25
$607.0M
$339.7M
Q3 25
$546.2M
$457.3M
Q2 25
$199.3M
$538.8M
Q1 25
$443.9M
$578.7M
Q4 24
$184.5M
$308.6M
Q3 24
$247.4M
$325.5M
Free Cash Flow
RBLX
RBLX
RMD
RMD
Q2 26
Q1 26
Q4 25
$308.6M
$311.2M
Q3 25
$443.6M
$414.4M
Q2 25
$176.7M
$508.2M
Q1 25
$426.5M
$557.9M
Q4 24
$120.6M
$288.0M
Q3 24
$218.0M
$307.7M
FCF Margin
RBLX
RBLX
RMD
RMD
Q2 26
Q1 26
Q4 25
21.8%
21.9%
Q3 25
32.6%
31.0%
Q2 25
16.3%
37.7%
Q1 25
41.2%
43.2%
Q4 24
12.2%
22.5%
Q3 24
23.7%
25.1%
Capex Intensity
RBLX
RBLX
RMD
RMD
Q2 26
Q1 26
Q4 25
21.1%
2.0%
Q3 25
7.5%
3.2%
Q2 25
2.1%
2.3%
Q1 25
1.7%
1.6%
Q4 24
6.5%
1.6%
Q3 24
3.2%
1.5%
Cash Conversion
RBLX
RBLX
RMD
RMD
Q2 26
Q1 26
Q4 25
0.87×
Q3 25
1.31×
Q2 25
1.42×
Q1 25
1.59×
Q4 24
0.90×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons